Hematology/Oncology

Top Story

Dasatinib improves outcomes vs. imatinib for pediatric ALL subset

Dasatinib improves outcomes vs. imatinib for pediatric ALL subset
January 17, 2020
Feature

Physicians weigh risks, rewards of social media for clinical trial recruitment

January 17, 2020
Less than 5% of eligible adults participate in cancer clinical trials, even in the information age when more opportunities exist than ever before to raise awareness of…
Trend Watch

Cytovia partners with UCSF, New York Stem Cell Foundation to develop novel CAR-NK cell therapies

January 17, 2020
Cytovia Therapeutics announced research partnerships with both The New York Stem Cell Foundation Research Institute and University of California, San Francisco, for the…
Feature

Psychology fellowship focuses on emotional well-being of patients with cancer

January 17, 2020
University of Kansas Medical Center’s department of psychiatry and behavioral sciences and University of Kansas Cancer Center have developed a clinical health…
In the Journals

High BMI linked to longer survival with immunotherapy for non-small cell lung cancer

January 16, 2020
High baseline BMI appeared to be independently associated with improved survival among patients with non-small cell lung cancer who received atezolizumab, according to…
More Headlines »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next